The AbVax study is looking at some new types of treatment for HIV. These treatments are being tested to see if they can keep your viral load undetectable without medication.

Your viral load is the amount of virus in your blood. This is usually controlled using antiretroviral therapy, or ‘ART’.

The study will look at what happens to the HIV virus and immune system in blood samples. It will also measure how long the viral load stays undetectable without ART.

When HIV becomes detectable in a blood test (viral rebound) you will be asked to restart your ART.

AbVax is open to people aged 18 to 64 who are living with HIV.

You need to be on antiretroviral therapy (ART) with an undetectable viral load for more than a year.